Page last updated: 2024-08-26

mizoribine and Diabetic Nephropathies

mizoribine has been researched along with Diabetic Nephropathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hyodo, N; Hyodo, T; Imakiire, T; Kikuchi, Y; Miura, S; Saigusa, T; Suzuki, S; Yamada, M	1

Other Studies

1 other study(ies) available for mizoribine and Diabetic Nephropathies

Article	Year
Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:8 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CCL2; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrosis; Glomerulosclerosis, Focal Segmental; Immunoenzyme Techniques; IMP Dehydrogenase; Macrophages; Male; Nephritis, Interstitial; Osteopontin; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleosides; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005

Article

Year

Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:8

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CCL2; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrosis; Glomerulosclerosis, Focal Segmental; Immunoenzyme Techniques; IMP Dehydrogenase; Macrophages; Male; Nephritis, Interstitial; Osteopontin; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleosides; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Transforming Growth Factor beta1

2005